These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 25501959)

  • 61. "Necklace" fibers, a new histological marker of late-onset MTM1-related centronuclear myopathy.
    Bevilacqua JA; Bitoun M; Biancalana V; Oldfors A; Stoltenburg G; Claeys KG; Lacène E; Brochier G; Manéré L; Laforêt P; Eymard B; Guicheney P; Fardeau M; Romero NB
    Acta Neuropathol; 2009 Mar; 117(3):283-91. PubMed ID: 19084976
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Allele-specific silencing therapy for Dynamin 2-related dominant centronuclear myopathy.
    Trochet D; Prudhon B; Beuvin M; Peccate C; Lorain S; Julien L; Benkhelifa-Ziyyat S; Rabai A; Mamchaoui K; Ferry A; Laporte J; Guicheney P; Vassilopoulos S; Bitoun M
    EMBO Mol Med; 2018 Feb; 10(2):239-253. PubMed ID: 29246969
    [TBL] [Abstract][Full Text] [Related]  

  • 63. DNM2 levels normalization improves muscle phenotypes of a novel mouse model for moderate centronuclear myopathy.
    de Carvalho Neves J; Moschovaki-Filippidou F; Böhm J; Laporte J
    Mol Ther Nucleic Acids; 2023 Sep; 33():321-334. PubMed ID: 37547294
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Correlative SICM-FCM reveals changes in morphology and kinetics of endocytic pits induced by disease-associated mutations in dynamin.
    Ali T; Bednarska J; Vassilopoulos S; Tran M; Diakonov IA; Ziyadeh-Isleem A; Guicheney P; Gorelik J; Korchev YE; Reilly MM; Bitoun M; Shevchuk A
    FASEB J; 2019 Jul; 33(7):8504-8518. PubMed ID: 31017801
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Centronuclear myopathies: genotype-phenotype correlation and frequency of defined genetic forms in an Italian cohort.
    Fattori F; Maggi L; Bruno C; Cassandrini D; Codemo V; Catteruccia M; Tasca G; Berardinelli A; Magri F; Pane M; Rubegni A; Santoro L; Ruggiero L; Fiorini P; Pini A; Mongini T; Messina S; Brisca G; Colombo I; Astrea G; Fiorillo C; Bragato C; Moroni I; Pegoraro E; D'Apice MR; Alfei E; Mora M; Morandi L; Donati A; Evilä A; Vihola A; Udd B; Bernansconi P; Mercuri E; Santorelli FM; Bertini E; D'Amico A
    J Neurol; 2015 Jul; 262(7):1728-40. PubMed ID: 25957634
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Characterization of a novel zebrafish model of SPEG-related centronuclear myopathy.
    Espinosa KG; Geissah S; Groom L; Volpatti J; Scott IC; Dirksen RT; Zhao M; Dowling JJ
    Dis Model Mech; 2022 May; 15(5):. PubMed ID: 35293586
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dynamin 2 (DNM2) as Cause of, and Modifier for, Human Neuromuscular Disease.
    Zhao M; Maani N; Dowling JJ
    Neurotherapeutics; 2018 Oct; 15(4):966-975. PubMed ID: 30426359
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A new centronuclear myopathy phenotype due to a novel dynamin 2 mutation.
    Bitoun M; Bevilacqua JA; Eymard B; Prudhon B; Fardeau M; Guicheney P; Romero NB
    Neurology; 2009 Jan; 72(1):93-5. PubMed ID: 19122038
    [No Abstract]   [Full Text] [Related]  

  • 69. Structural insights into the centronuclear myopathy-associated functions of BIN1 and dynamin 2.
    Hohendahl A; Roux A; Galli V
    J Struct Biol; 2016 Oct; 196(1):37-47. PubMed ID: 27343996
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mitochondrial alterations in dynamin 2-related centronuclear myopathy.
    Zanoteli E; Vergani N; Campos Y; Vainzof M; Oliveira AS; d'Azzo A
    Arq Neuropsiquiatr; 2009 Mar; 67(1):102-4. PubMed ID: 19330221
    [No Abstract]   [Full Text] [Related]  

  • 71. Centronuclear myopathy due to a de novo dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene.
    Jungbluth H; Zhou H; Sewry CA; Robb S; Treves S; Bitoun M; Guicheney P; Buj-Bello A; Bönnemann C; Muntoni F
    Neuromuscul Disord; 2007 Apr; 17(4):338-45. PubMed ID: 17376685
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mild functional differences of dynamin 2 mutations associated to centronuclear myopathy and Charcot-Marie Tooth peripheral neuropathy.
    Koutsopoulos OS; Koch C; Tosch V; Böhm J; North KN; Laporte J
    PLoS One; 2011; 6(11):e27498. PubMed ID: 22096584
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Centronuclear Myopathy Caused by Defective Membrane Remodelling of Dynamin 2 and BIN1 Variants.
    Fujise K; Noguchi S; Takeda T
    Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682949
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Calcium homeostasis alterations in a mouse model of the Dynamin 2-related centronuclear myopathy.
    Fraysse B; Guicheney P; Bitoun M
    Biol Open; 2016 Nov; 5(11):1691-1696. PubMed ID: 27870637
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Mice carrying an analogous heterozygous dynamin 2 K562E mutation that causes neuropathy in humans develop predominant characteristics of a primary myopathy.
    Pereira JA; Gerber J; Ghidinelli M; Gerber D; Tortola L; Ommer A; Bachofner S; Santarella F; Tinelli E; Lin S; Rüegg MA; Kopf M; Toyka KV; Suter U
    Hum Mol Genet; 2020 May; 29(8):1253-1273. PubMed ID: 32129442
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dynamin-2 reduction rescues the skeletal myopathy of a SPEG-deficient mouse model.
    Li Q; Lin J; Widrick JJ; Luo S; Li G; Zhang Y; Laporte J; Perrella MA; Liu X; Agrawal PB
    JCI Insight; 2022 Aug; 7(15):. PubMed ID: 35763354
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Autosomal dominant centronuclear myopathy with unique clinical presentations.
    Lee JY; Min JH; Hong YH; Sung JJ; Park SH; Park SH; Lee KW; Park KS
    J Korean Med Sci; 2007 Dec; 22(6):1098-101. PubMed ID: 18162732
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Dynamin 2 the rescue for centronuclear myopathy.
    Demonbreun AR; McNally EM
    J Clin Invest; 2014 Mar; 124(3):976-8. PubMed ID: 24569368
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Phenotypic Spectrum of
    Hayes LH; Perdomini M; Aykanat A; Genetti CA; Paterson HL; Cowling BS; Freitag C; Beggs AH
    Neurol Genet; 2022 Dec; 8(6):e200027. PubMed ID: 36324371
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Amphiphysin (BIN1) negatively regulates dynamin 2 for normal muscle maturation.
    Cowling BS; Prokic I; Tasfaout H; Rabai A; Humbert F; Rinaldi B; Nicot AS; Kretz C; Friant S; Roux A; Laporte J
    J Clin Invest; 2017 Dec; 127(12):4477-4487. PubMed ID: 29130937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.